Lv Yuyu, Ren Ru, Tang Chengxiang, Song Kuimeng, Li Shunping, Wang Haipeng
Center for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.
NHC Key Laboratory of Health Economics and Policy Research (Shandong University), Jinan, People's Republic of China.
Patient Prefer Adherence. 2022 Aug 25;16:2335-2344. doi: 10.2147/PPA.S367985. eCollection 2022.
To evaluate preferences for medications among patients with type 2 diabetes mellitus (T2DM) from urban community health stations or rural village clinics in Shandong province, China.
We use a discrete choice experiment (DCE) to measure the medication preferences. Each patient completed six DCE choice sets. The attributes for the DCE questionnaire include mode of administration, out-of-pocket medication cost per month, fasting blood glucose control effect and frequency of hypoglycemia events. The conditional logit model (Clogit) and mixed logit model (MXL) were used to evaluate choice data.
A total of 887 patients with T2DM completed the survey. The mean age of participants was 64 years, 36.42% experienced complications, and the mean duration of diabetes was about 8 years. Overall, patients' ideal medication would not have hypoglycemia events, provide normal fasting glucose levels, have oral medication three times a day and lower monthly medication cost. Patients prioritized the frequency of hypoglycemia events (β=15.055, P < 0.01) and were willing to spend CNY 393.10 per month to avoid hypoglycemia events. For patients with higher educational levels and with longer diagnosis time, the effect of fasting blood glucose was more relevant than all other outcomes.
This study provides information on T2DM patients' preference for medications. Our results suggest that clinical doctors should present patients with a variety of pharmaceutical characteristics and include their preference into medication decision, which will improve patient adherence and health outcomes.
评估中国山东省城市社区卫生服务站或农村卫生室的2型糖尿病(T2DM)患者对药物的偏好。
我们使用离散选择实验(DCE)来测量药物偏好。每位患者完成六个DCE选择集。DCE问卷的属性包括给药方式、每月自付药费、空腹血糖控制效果和低血糖事件发生频率。使用条件logit模型(Clogit)和混合logit模型(MXL)评估选择数据。
共有887例T2DM患者完成调查。参与者的平均年龄为64岁,36.42%有并发症,糖尿病平均病程约8年。总体而言,患者理想的药物不会发生低血糖事件,能使空腹血糖水平正常,每日口服三次,且每月药费较低。患者将低血糖事件发生频率列为优先考虑因素(β=15.055,P<0.01),并且愿意每月花费393.10元来避免低血糖事件。对于教育程度较高和诊断时间较长的患者,空腹血糖的效果比所有其他结果更相关。
本研究提供了T2DM患者对药物偏好的信息。我们的结果表明,临床医生应向患者介绍各种药物特性,并将患者的偏好纳入用药决策,这将提高患者的依从性和健康结局。